Abstract:Bronchodilators are a standard medicine for treating airway obstructive diseases, and β2 adrenergic receptor agonists have been the most commonly used bronchodilators since their discovery. Strikingly, activation of G-protein-coupled bitter taste receptors (TAS2Rs) in airway smooth muscle (ASM) causes a stronger bronchodilation in vitro and in vivo than β2 agonists, implying that new and better bronchodilators could be developed. A critical step towards realizing this potential is to understand the mechanisms underlying this bronchodilation, which remain ill-defined. An influential hypothesis argues that bitter tastants generate localized Ca(2+) signals, as revealed in cultured ASM cells, to activate large-conductance Ca(2+)-activated K(+) channels, which in turn hyperpolarize the membrane, leading to relaxation. Here we report that in mouse primary ASM cells bitter tastants neither evoke localized Ca(2+) events nor alter spontaneous local Ca(2+) transients. Interestingly, they increase global intracellular [Ca(2+)]i, although to a much lower level than bronchoconstrictors. We show that these Ca(2+) changes in cells at rest are mediated via activation of the canonical bitter taste signaling cascade (i.e., TAS2R-gustducin-phospholipase Cβ [PLCβ]- inositol 1,4,5-triphosphate receptor [IP3R]), and are not sufficient to impact airway contractility. But activation of TAS2Rs fully reverses the increase in [Ca(2+)]i induced by bronchoconstrictors, and this lowering of the [Ca(2+)]i is necessary for bitter tastant-induced ASM cell relaxation. We further show that bitter tastants inhibit L-type voltage-dependent Ca(2+) channels (VDCCs), resulting in reversal in [Ca(2+)]i, and this inhibition can be prevented by pertussis toxin and G-protein βγ subunit inhibitors, but not by the blockers of PLCβ and IP3R. Together, we suggest that TAS2R stimulation activates two opposing Ca(2+) signaling pathways via Gβγ to increase [Ca(2+)]i at rest while blocking activated L-type VDCCs to induce bronchodilation of contracted ASM. We propose that the large decrease in [Ca(2+)]i caused by effective tastant bronchodilators provides an efficient cell-based screening method for identifying potent dilators from among the many thousands of available bitter tastants.

Tracheal brush cells release acetylcholine in response to bitter tastants for paracrine and autocrine signaling

Cholinergic epithelial cell with chemosensory traits in murine thymic medulla

Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction

Neuroendocrine cells initiate protective upper airway reflexes

Bitter taste receptor agonists regulate epithelial two-pore potassium channels via cAMP signaling

The cellular and molecular basis of bitter tastant-induced bronchodilation

Taste Receptors: Regulators of Sinonasal Innate Immunity

Bitter taste receptors stimulate phagocytosis in human macrophages through calcium, nitric oxide, and cyclic-GMP signaling

Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors

Acetylcholine Producing Innate Type 2 and 3 Lymphoid Cells Promote Protease Driven Allergic Lung Inflammation

A role for airway taste receptor modulation in the treatment of upper respiratory infections

Taste and smell GPCRs in the lung: Evidence for a previously unrecognized widespread chemosensory system

Type II taste cells participate in mucosal immune surveillance

B cells modulate lung antiviral inflammatory responses via the neurotransmitter acetylcholine

Turbinate-homing IgA-secreting cells originate in the nasal lymphoid tissues

TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells

Gingival solitary chemosensory cells are immune sentinels for periodontitis

An Airway Protection Program Revealed by Sweeping Genetic Control of Vagal Afferents

A brainstem circuit controls cough-like airway defensive behaviors in mice

Chemical receptors of the arytenoid: A comparison of human and mouse

Motor control of airway goblet cells and glands